Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | TDO2 | P48775 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
| ▸ | AR | P10275 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31439258 | 1.00 | MEN1 (0.42) | MEN1KMT2ARAB9ATDO2HPGD | |
| SCHEMBL24057196 | 0.88 | TBK1 (0.34) | MEN1KMT2ARAB9ATDO2HPGD | |
| SCHEMBL26834213 | 0.87 | AHR (0.49) | MEN1KMT2ARAB9AHPGDCA1 | |
| SCHEMBL26424274 | 0.87 | TNKS (0.44) | MEN1KMT2ARAB9ASMN1; SMN2CYP1B1 | |
| SCHEMBL25663343 | 0.87 | MEN1 (0.47) | MEN1KMT2ARAB9AHPGDTP53 | |
| SCHEMBL25662863 | 0.85 | TNKS (0.35) | MEN1KMT2ARAB9ATDO2HPGD | |
| SCHEMBL25462978 | 0.83 | MEN1 (0.39) | MEN1KMT2ARAB9AHPGDTP53 | |
| SCHEMBL25462969 | 0.82 | KMT2A (0.38) | MEN1KMT2ARAB9AHPGDTP53 | |
| SCHEMBL23972148 | 0.81 | KMT2A (0.38) | MEN1KMT2ARAB9ATDO2HPGD | |
| SCHEMBL24057488 | 0.81 | CYP1A1 (0.37) | MEN1KMT2AHPGDTP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105820192-B | Metal complexes comprising novel ligand structures | 通用显示公司 | 2020-04-07 | — | — | CN | disclosed |
| US-20170237019-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-08-17 | — | — | US | disclosed |
| US-9634264-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-04-25 | — | — | US | disclosed |
| US-9359549-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-9359549-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-9359549-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-20140131663-A1 | Iridium Complexes With Aza-Benzo Fused Ligands | UNIVERSAL DISPLAY CORPORATION (US) | 2014-05-15 | — | — | US | disclosed |
| EP-2417215-B1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORP (US) | 2014-05-07 | — | — | EP | disclosed |
| US-20120061654-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120061654-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120061654-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2012-03-15 | — | — | US | disclosed |
| EP-2417215-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | Universal Display Corporation (US) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010118029-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010118029-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | UNIVERSAL DISPLAY CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120061654-A1 | METAL COMPLEX COMPRISING NOVEL LIGAND STRUCTURES | ZFX, VDAC1, PDCD1LG2 | MEN1 1853/4885KMT2A 625/4885RAB9A 2332/4885 |
| US-20170237019-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | MEN1 4723/4885KMT2A 2518/4885RAB9A 1851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.